1. Home
  2. PROP vs CTMX Comparison

PROP vs CTMX Comparison

Compare PROP & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Prairie Operating Co.

PROP

Prairie Operating Co.

HOLD

Current Price

$1.83

Market Cap

93.6M

Sector

Finance

ML Signal

HOLD

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

HOLD

Current Price

$4.23

Market Cap

596.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PROP
CTMX
Founded
2001
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
93.6M
596.2M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
PROP
CTMX
Price
$1.83
$4.23
Analyst Decision
Buy
Strong Buy
Analyst Count
5
6
Target Price
$6.75
$6.50
AVG Volume (30 Days)
1.4M
2.8M
Earning Date
02-15-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
50.22
EPS
N/A
0.24
Revenue
$166,577,000.00
$113,631,000.00
Revenue This Year
$3,967.26
N/A
Revenue Next Year
$71.16
N/A
P/E Ratio
N/A
$17.74
Revenue Growth
N/A
N/A
52 Week Low
$1.57
$0.40
52 Week High
$10.58
$4.66

Technical Indicators

Market Signals
Indicator
PROP
CTMX
Relative Strength Index (RSI) 56.33 54.87
Support Level $1.66 $4.07
Resistance Level $1.80 $4.48
Average True Range (ATR) 0.10 0.27
MACD 0.02 -0.00
Stochastic Oscillator 91.38 45.96

Price Performance

Historical Comparison
PROP
CTMX

About PROP Prairie Operating Co.

Prairie Operating Co is a Houston-based independent energy company engaged in the development and acquisition of oil and natural gas resources in the United States. The Company's assets and operations are concentrated in the oil and liquids-rich regions of the Denver-Julesburg (DJ) Basin, with a focus on the Niobrara and Codell formations. The Company is committed to the responsible development of its oil and natural gas resources and is focused on maximizing returns through consistent growth, capital discipline, and sustainable cash flow generation.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: